KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) EBT Margin (2017 - 2025)

Moderna (MRNA) has disclosed EBT Margin for 9 consecutive years, with 117.85% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin fell 1648.0% to 117.85% in Q4 2025 year-over-year; TTM through Dec 2025 was 142.39%, a 3545.0% decrease, with the full-year FY2025 number at 142.39%, down 3092.0% from a year prior.
  • EBT Margin was 117.85% for Q4 2025 at Moderna, down from 18.41% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 75.02% in Q4 2021 to a low of 892.59% in Q1 2025.
  • A 5-year average of 164.31% and a median of 7.63% in 2024 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: skyrocketed 161505bps in 2021, then tumbled -68122bps in 2024.
  • Moderna's EBT Margin stood at 75.02% in 2021, then plummeted by -57bps to 32.55% in 2022, then crashed by -92bps to 2.49% in 2023, then plummeted by -4171bps to 101.37% in 2024, then decreased by -16bps to 117.85% in 2025.
  • Per Business Quant, the three most recent readings for MRNA's EBT Margin are 117.85% (Q4 2025), 18.41% (Q3 2025), and 576.06% (Q2 2025).